ERIC DOBMEIER Insider Trading
Get free email notifications about insider trading for ERIC DOBMEIER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERIC DOBMEIER. ERIC DOBMEIER is a Chief Business Officer in SEATTLE GENETICS INC /WA ($SGEN) and a Chief Operating Officer in SEATTLE GENETICS INC /WA ($SGEN) and a Sr. VP, Corporate Development in SEATTLE GENETICS INC /WA ($SGEN) and a V. P., Corporate Affairs in SEATTLE GENETICS INC /WA ($SGEN) and a Vice President, in SEATTLE GENETICS INC /WA ($SGEN) and a Director in STEMLINE THERAPEUTICS INC ($STML) and a President, CEO in ADURO BIOTECH, INC. ($ADRO) and a Director in Adaptive Biotechnologies Corp ($ADPT) and a Director in Versartis, Inc. ($VSAR) and a Director in Atara Biotherapeutics, Inc. ($ATRA).
Address: 21823 30TH DRIVE SE BOTHELL 98021 WA
Companies in which ERIC DOBMEIER is an Insider
Adaptive Biotechnologies Corp
Trading Symbol: ADPTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC DOBMEIER: Director
Holdings: 1,504 shares
Latest Transaction: Feb 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aravive, Inc.
Trading Symbol: ARAVIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ERIC DOBMEIER: Director
Holdings: 18,160 shares
Current Value: $241,528
Latest Transaction: Dec 22 2017
$ARAV Market Capitalization: $474.95M
$ARAV Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Atara Biotherapeutics, Inc.
Trading Symbol: ATRAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC DOBMEIER: Director
Holdings: 28,000 shares
Current Value: $421,400
Latest Transaction: Jun 17 2020
$ATRA Market Capitalization: $434.34M
$ATRA Previous Close: $15.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CHINOOK THERAPEUTICS, INC.
Trading Symbol: ADROIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ERIC DOBMEIER: President, CEO
Holdings: 97,837 shares
Current Value: $1,095,774
Latest Transaction: Jun 15 2021
$ADRO Market Capitalization: $745.72M
$ADRO Previous Close: $11.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC DOBMEIER: Chief Operating Officer, Chief Business Officer, Sr. VP, Corporate Development, V. P., Corporate Affairs, Vice President,
Holdings: 121,153 shares
Current Value: $7,364,891
Latest Transaction: Dec 06 2017
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
STEMLINE THERAPEUTICS INC
Trading Symbol: STMLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ERIC DOBMEIER: Director
Holdings: 27,963 shares
Current Value: $173,371
Latest Transaction: Jun 20 2017
$STML Market Capitalization: $118.68M
$STML Previous Close: $6.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ERIC DOBMEIER
Sentiment: All, ADPT, ARAV, ATRA, ADRO, SGEN, STML
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Option Exercise | M | 0.35 | 20,000 | 7,000 | 423,358 | |
Jun 15 2021 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | M | 0.35 | 20,000 | 7,000 | 97,837 | 77.8 K to 97.8 K (+25.69 %) |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Option Exercise | A | 66.50 | 3,759 | 249,974 | 3,759 | |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Grant | A | 0.00 | 1,504 | 0 | 1,504 | 0 to 1.5 K |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.00 | 60,743 | 0 | 60,743 | |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 15.14 | 178,600 | 2,704,004 | 178,600 | |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Option Exercise | M | 6.32 | 10,000 | 63,200 | 35,000 |